David W Meline - Net Worth and Insider Trading

David W Meline Net Worth

The estimated net worth of David W Meline is at least $14 Million dollars as of 2024-04-25. David W Meline is the EVP & CFO of Amgen Inc and owns about 49,378 shares of Amgen Inc (AMGN) stock worth over $13 Million. David W Meline is the CFO of Moderna Inc and owns about 2,857 shares of Moderna Inc (MRNA) stock worth over $310,984. David W Meline is also the Director of Pacific Biosciences of California Inc and owns about 40,000 shares of Pacific Biosciences of California Inc (PACB) stock worth over $54,400. Besides these, David W Meline also holds 3M Co (MMM) . Details can be seen in David W Meline's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David W Meline has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).

Transaction Summary of David W Meline

To

David W Meline Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W Meline owns 5 companies in total, including Moderna Inc (MRNA) , Amgen Inc (AMGN) , and 3M Co (MMM) among others .

Click here to see the complete history of David W Meline’s form 4 insider trades.

Insider Ownership Summary of David W Meline

Ticker Comapny Transaction Date Type of Owner
MRNA Moderna Inc 2022-08-10 Chief Financial Officer
AMGN Amgen Inc 2019-11-25 EVP & CFO
MMM 3M Co 2013-10-29 VP CORP CNTRLR & CF ACCTG OFCR
HPQ HP Inc 2023-11-01 director
PACB Pacific Biosciences of California Inc 2024-03-06 director

David W Meline Latest Holdings Summary

David W Meline currently owns a total of 4 stocks. Among these stocks, David W Meline owns 49,378 shares of Amgen Inc (AMGN) as of November 25, 2019, with a value of $13 Million and a weighting of 97.36%. David W Meline owns 2,857 shares of Moderna Inc (MRNA) as of August 10, 2022, with a value of $310,984 and a weighting of 2.25%. David W Meline also owns 40,000 shares of Pacific Biosciences of California Inc (PACB) as of March 6, 2024, with a value of $54,400 and a weighting of 0.39%. The other 1 stocks 3M Co (MMM) have a combined weighting of 0% among all his current holdings.

Latest Holdings of David W Meline

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2019-11-25 49,378 273.01 13,480,688
MRNA Moderna Inc 2022-08-10 2,857 108.85 310,984
PACB Pacific Biosciences of California Inc 2024-03-06 40,000 1.36 54,400
MMM 3M Co 2013-10-29 0 92.02 0

Holding Weightings of David W Meline


David W Meline Form 4 Trading Tracker

According to the SEC Form 4 filings, David W Meline has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 8,737 shares on November 25, 2019, which brought David W Meline around $2 Million.

According to the SEC Form 4 filings, David W Meline has made a total of 3 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Moderna Inc is the sale of 164 shares on August 10, 2022, which brought David W Meline around $28,480.

According to the SEC Form 4 filings, David W Meline has made a total of 1 transactions in Pacific Biosciences of California Inc (PACB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pacific Biosciences of California Inc is the acquisition of 40,000 shares on March 6, 2024, which cost David W Meline around $176,000.

More details on David W Meline's insider transactions can be found in the Insider Trading History of David W Meline table.

Insider Trading History of David W Meline

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W Meline Trading Performance

GuruFocus tracks the stock performance after each of David W Meline's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David W Meline is %. GuruFocus also compares David W Meline's trading performance to market benchmark return within the same time period. The performance of stocks bought by David W Meline within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David W Meline's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David W Meline

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.76
Relative Return to S&P 500(%) -21.71

David W Meline Ownership Network

Ownership Network List of David W Meline

No Data

Ownership Network Relation of David W Meline


David W Meline Owned Company Details

What does Moderna Inc do?

Who are the key executives at Moderna Inc?

David W Meline is the Chief Financial Officer of Moderna Inc. Other key executives at Moderna Inc include director & 10 percent owner Noubar Afeyan , President Stephen Hoge , and Chief Financial Officer James M Mock .

Moderna Inc (MRNA) Insider Trades Summary

Over the past 18 months, David W Meline made no insider transaction in Moderna Inc (MRNA). Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 565,000 shares made by Noubar Afeyan , a net sale of 2,793,506 shares made by Stephane Bancel , and a net sale of 171,017 shares made by Stephen Hoge .

In summary, during the past 3 months, insiders sold 177,577 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 177,577 shares. During the past 18 months, 3,564,860 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,564,860 shares.

Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Moderna Inc Insider Transactions

No Available Data

David W Meline Mailing Address

Above is the net worth, insider trading, and ownership report for David W Meline. You might contact David W Meline via mailing address: 3m Company, 3m Office Of General Counsel, St Paul Mn 55144-1000.

Discussions on David W Meline

No discussions yet.